Skin & HairPreclinicalAnimal Studies

Glow Protocol

Also known as Glow Stack, Glow Blend, Skin Rejuvenation Stack

Multi-peptide blend designed for anti-aging, skin rejuvenation, collagen production, and cellular regeneration through combined tissue repair mechanisms.

Preclinical Research (Components)

Regulatory Pathway

Preclinical
Phase I
Phase II
Phase III
Phase IV
Approved

Dosing Protocol

Typical Dose

Standard vial: BPC-157 (5mg), TB-500 (10mg), GHK-Cu (27mg)

Frequency

Once daily

Duration

8-12 weeks for visible results

Community-reported dosing. Individual results vary. Not a medical recommendation.
Typical community protocol: Standard vial: BPC-157 (5mg), TB-500 (10mg), GHK-Cu (27mg) via Subcutaneous injection, Once daily. Dose range: Per component ratios (5:1:1 GHK-Cu:TB-500:BPC-157). Duration: 8-12 weeks for visible results.

Timing & Administration

Administer via Subcutaneous injection. Frequency: Once daily.

Mechanism of Action

GHK-Cu stimulates collagen and elastin synthesis while reducing matrix metalloproteinases. BPC-157 promotes tissue healing and angiogenesis. TB-500 enhances cell migration and new blood vessel formation.

Research Summary

Evidence level: animal studies. Clinical status: Preclinical Research (Components).

Side Effects & Safety

Important Warnings

  • Components individually restricted from compounding
Injection site reactions
temporary skin flushing
mild headache (rare)
fatigue during initial use

References

No references available.